These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36123773)

  • 1. Incidence, prevalence and regional distribution of systemic sclerosis and related interstitial lung Disease: A nationwide retrospective cohort study.
    Knarborg M; Hyldgaard C; Bendstrup E; Davidsen JR; Løkke A; Shaker SB; Hilberg O
    Chron Respir Dis; 2022; 19():14799731221125559. PubMed ID: 36123773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity and mortality in systemic sclerosis and matched controls: Impact of interstitial lung disease. A population based cohort study based on health registry data.
    Knarborg M; Hyldgaard C; Bendstrup E; Davidsen JR; Løkke A; Shaker SB; Hilberg O
    Chron Respir Dis; 2023; 20():14799731231195041. PubMed ID: 37596992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and prevalence of systemic sclerosis and systemic sclerosis with interstitial lung disease in the United States.
    Fan Y; Bender S; Shi W; Zoz D
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1539-1547. PubMed ID: 32996805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study.
    Li Q; Wallace L; Patnaik P; Alves M; Gahlemann M; Kohlbrenner V; Raabe C; Wang JR; Garry EM
    Rheumatology (Oxford); 2021 Apr; 60(4):1915-1925. PubMed ID: 33155024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence Rate and Prevalence of Systemic Sclerosis and Systemic Sclerosis-Associated Interstitial Lung Disease in Japan: Analysis Using Japanese Claims Databases.
    Kuwana M; Saito A; Sakamoto W; Raabe C; Saito K
    Adv Ther; 2022 May; 39(5):2222-2235. PubMed ID: 35316503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence, prevalence and long-term progression of Goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in flanders: A retrospective cohort study.
    Vandecasteele E; Melsens K; Vanhaecke A; Blockmans D; Bonroy C; Carton C; Deschepper E; De Keyser F; Houssiau F; Piette Y; Vanthuyne M; Verbeke K; Westhovens R; Wuyts WA; De Langhe E; Brusselle G; Smith V
    Semin Arthritis Rheum; 2021 Oct; 51(5):969-976. PubMed ID: 34403812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Sclerosis and Associated Interstitial Lung Disease in Ontario, Canada: An Examination of Prevalence and Survival Over 10 Years.
    Pope JE; Quansah K; Hassan S; Seung SJ; Flavin J; Kolb M
    J Rheumatol; 2021 Sep; 48(9):1427-1434. PubMed ID: 33795325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement.
    Fischer A; Kong AM; Swigris JJ; Cole AL; Raimundo K
    J Rheumatol; 2018 Feb; 45(2):235-241. PubMed ID: 29142033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare Resource Utilization Among Patients in England with Systemic Sclerosis-Associated Interstitial Lung Disease: A Retrospective Database Analysis.
    Gayle A; Schoof N; Alves M; Clarke D; Raabe C; Das P; Del Galdo F; Maher TM
    Adv Ther; 2020 May; 37(5):2460-2476. PubMed ID: 32319038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort study.
    Bauer PR; Schiavo DN; Osborn TG; Levin DL; St Sauver J; Hanson AC; Schroeder DR; Ryu JH
    Chest; 2013 Aug; 144(2):571-577. PubMed ID: 23450327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and indirect costs of systemic sclerosis and associated interstitial lung disease: A nationwide population-based cohort study.
    Knarborg M; Løkke A; Hilberg O; Ibsen R; Sikjaer MG
    Respirology; 2022 May; 27(5):341-349. PubMed ID: 35224821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: a EUSTAR database analysis.
    Campochiaro C; Hoffmann-Vold AM; Avouac J; Henes J; de Vries-Bouwstra J; Smith V; Siegert E; Airò P; Oksel F; Pellerito R; Vanthuyne M; Pozzi MR; Inanc M; Sibilia J; Gabrielli A; Distler O; Allanore Y;
    Rheumatology (Oxford); 2023 Jul; 62(7):2483-2491. PubMed ID: 36413079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.
    Guler SA; Kwan JM; Winstone TA; Milne KM; Dunne JV; Wilcox PG; Ryerson CJ
    Respir Med; 2017 Aug; 129():1-7. PubMed ID: 28732817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: Inception cohort study.
    Wangkaew S; Euathrongchit J; Wattanawittawas P; Kasitanon N; Louthrenoo W
    Mod Rheumatol; 2016 Jul; 26(4):588-93. PubMed ID: 26561397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Prevalence of Acute Exacerbation of Interstitial Lung Disease in Japanese Patients with Systemic Sclerosis.
    Tomiyama F; Watanabe R; Ishii T; Kamogawa Y; Fujita Y; Shirota Y; Sugimura K; Fujii H; Harigae H
    Tohoku J Exp Med; 2016 Aug; 239(4):297-305. PubMed ID: 27487743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort.
    Hoffmann-Vold AM; Fretheim H; Halse AK; Seip M; Bitter H; Wallenius M; Garen T; Salberg A; Brunborg C; Midtvedt Ø; Lund MB; Aaløkken TM; Molberg Ø
    Am J Respir Crit Care Med; 2019 Nov; 200(10):1258-1266. PubMed ID: 31310156
    [No Abstract]   [Full Text] [Related]  

  • 18. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
    Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
    Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of progressive fibrosing interstitial lung disease in patients with systemic sclerosis: insight from the CRDC cohort study.
    Hui M; Duan X; Zhou J; Li M; Wang Q; Zhao J; Hou Y; Xu D; Zeng X
    RMD Open; 2024 Mar; 10(1):. PubMed ID: 38519110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between gastroprotective agents and risk of incident interstitial lung disease in systemic sclerosis.
    Hurtubise R; Hudson M; Gyger G; Wang M; Steele RJ; Baron M; ; Hoa S
    Respir Med; 2021; 185():106482. PubMed ID: 34089970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.